CliffBio
small molecule

FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE

BENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM

Loss of exclusivityNovember 2037latest FDA-listed patent expiry
CompanyBAUSCH AND LOMB IRELAND LTD

Drug detail

Brand nameFLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE
Active ingredientBENOXINATE HYDROCHLORIDE; FLUORESCEIN SODIUM
Strength0.4%;0.3%
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalMarch 2020
Marketing statusRX

Listed patents

PatentExpiresType
10842872November 2037use U-3001
10632197November 2037product
10293047November 2037product

More from BAUSCH AND LOMB IRELAND LTD

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.